Accolade Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Raj Singh
Algemeen directeur
US$3.8m
Totale compensatie
Percentage CEO-salaris | 13.1% |
Dienstverband CEO | 9yrs |
Eigendom CEO | 1.0% |
Management gemiddelde ambtstermijn | 3.5yrs |
Gemiddelde ambtstermijn bestuur | 5.3yrs |
Recente managementupdates
Recent updates
Accolade: Consider Both Short-Term Revenue Outlook And Rumored Takeover
Sep 09Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch
Jun 29Accolade: Mixed Guidance (Rating Downgrade)
Jun 28Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?
Jun 05Accolade: Staying Bullish On Favorable Developments
Apr 05Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price
Feb 17Accolade: Remain Confident That FY25 Guided Growth Is Achievable
Jan 17Accolade: Turning Bullish After Beat-And-Raise Quarter (Rating Upgrade)
Jan 11Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge
Jun 13Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?
May 02An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued
Feb 05Accolade: Inching Closer To Profitability
Oct 17Accolade Q2 2023 Earnings Preview
Oct 05Accolade: Fair And Reasonably Priced, But Needs More Time
Aug 09Accolade Q1 2023 Earnings Preview
Jun 29Accolade: Little Recent Applause
Mar 28Accolade Impresses With Revenue Growth But Faces Operating Losses
Dec 16Accolade: I May Add To My Position
Oct 18Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 11Accolade, Inc. 2021 Q4 - Results - Earnings Call Presentation
May 06Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Aug 31 2024 | n/a | n/a | -US$80m |
May 31 2024 | n/a | n/a | -US$89m |
Feb 29 2024 | US$4m | US$500k | -US$100m |
Nov 30 2023 | n/a | n/a | -US$123m |
Aug 31 2023 | n/a | n/a | -US$142m |
May 31 2023 | n/a | n/a | -US$155m |
Feb 28 2023 | US$2m | US$500k | -US$460m |
Nov 30 2022 | n/a | n/a | -US$464m |
Aug 31 2022 | n/a | n/a | -US$401m |
May 31 2022 | n/a | n/a | -US$417m |
Feb 28 2022 | US$6m | US$471k | -US$123m |
Nov 30 2021 | n/a | n/a | -US$93m |
Aug 31 2021 | n/a | n/a | -US$132m |
May 31 2021 | n/a | n/a | -US$85m |
Feb 28 2021 | US$3m | US$400k | -US$51m |
Nov 30 2020 | n/a | n/a | -US$48m |
Aug 31 2020 | n/a | n/a | -US$50m |
May 31 2020 | n/a | n/a | -US$49m |
Feb 29 2020 | US$3m | US$394k | -US$51m |
Nov 30 2019 | n/a | n/a | -US$56m |
Feb 28 2019 | US$574k | US$350k | -US$56m |
Compensatie versus markt: De totale vergoeding ($USD 3.82M ) Raj } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.48M ).
Compensatie versus inkomsten: De vergoeding van Raj is gestegen terwijl het bedrijf verliesgevend is.
CEO
Raj Singh (56 yo)
9yrs
Tenure
US$3,823,597
Compensatie
Mr. Rajeev Singh, also known as Raj, serves as Director at Amperity, Inc. He has been the Chief Executive Officer and Executive Director of Accolade, Inc. since November 2015 and also serves as its Chairma...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman of the Board & CEO | 9yrs | US$3.82m | 0.98% $ 2.5m | |
President | 5.8yrs | US$1.79m | 0.25% $ 632.2k | |
CFO & Treasurer | 9.8yrs | US$1.78m | 0.25% $ 650.7k | |
Executive VP | 6.6yrs | US$1.02m | 0.064% $ 165.5k | |
Senior Vice President of Operations | 1.6yrs | geen gegevens | geen gegevens | |
Chief Accounting Officer | 1.4yrs | geen gegevens | 0.068% $ 174.2k | |
Senior Vice President of Investor Relations | 4.1yrs | geen gegevens | geen gegevens | |
Chief People Officer & Senior Vice President | less than a year | geen gegevens | geen gegevens | |
Executive Vice President of Engineering | 2.8yrs | geen gegevens | geen gegevens | |
Executive VP | 4.9yrs | geen gegevens | geen gegevens | |
Executive VP and GM of Health Plan & Expert Medical Opinion Business | less than a year | geen gegevens | geen gegevens | |
Senior VP & Chief Medical Officer - Advocacy | 1.2yrs | geen gegevens | geen gegevens |
3.5yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ACCD wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman of the Board & CEO | 9yrs | US$3.82m | 0.98% $ 2.5m | |
Executive VP | 5.8yrs | geen gegevens | geen gegevens | |
Independent Director | 5.4yrs | US$237.00k | 0% $ 0 | |
Independent Director | 8.3yrs | US$222.00k | 0.034% $ 88.8k | |
Director | 1.8yrs | geen gegevens | 0.43% $ 1.1m | |
Independent Director | 4.8yrs | US$222.00k | 0.034% $ 88.8k | |
Lead Independent Director | 5.2yrs | US$262.00k | 0.035% $ 90.7k | |
Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 3.4yrs | US$226.41k | 0.053% $ 135.8k | |
Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Medical Advisory Board | no data | geen gegevens | geen gegevens |
5.3yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ACCD wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).